Back to 
TWO SIGMA ADVISERS, LP
TWO SIGMA ADVISERS, LP
XLO
2 quarters
Position history for TWO SIGMA ADVISERS, LP's holdings in XILIO THERAPEUTICS INC
No. Two Sigma Advisers exited its XLO (Xilio Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 29,689 shares worth $25,019. Two Sigma Advisers first reported XLO in Q3 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$25,019
Total Shares Change
-29,689
Quarter-by-Quarter History